Star Seyedkazemi

A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

Scott L. Friedman, Vlad Ratziu, Stephen A. Harrison et al. · Hepatology · 2017 · 658 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study

Vlad Ratziu, Arun J. Sanyal, Stephen A. Harrison et al. · Hepatology · 2020 · 361 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations

Patrick Lowe, Caroline Morel, Aditya Ambade et al. · Journal of Neuroinflammation · 2020 · 126 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design

Quentin M. Anstee, Brent A. Neuschwander‐Tetri, Vincent Wai‐Sun Wong et al. · Contemporary Clinical Trials · 2019 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial

Marcos Pedrosa, Star Seyedkazemi, Sven Francque et al. · Contemporary Clinical Trials · 2019 · 112 citations

Medicine, Pharmacology, Pharmacotherapy +10